Tonsil Surgery in Recurrent or Chronic Tonsillitis

NCT04657549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2023-06-12

No results posted yet for this study

Summary

Tonsil surgery is common in adults with recurrent or chronic tonsillitis. The surgical techniques include either partial or total surgical removal of the palatal tonsils (tonsillotomy, TT, and tonsillectomy, TE, respectively). The aim of this study is to find out, whether tonsil surgery improves the quality of life in these patients and whether the lighter TT is as effective as TE. Our main outcome is the disease-specific Tonsillectomy Outcome Inventory-14 (TOI-14) quality of life questionnaire score at 6 months follow-up.

Conditions

  • Tonsillitis Recurrent
  • Tonsillitis Chronic

Interventions

PROCEDURE

Tonsillectomy

Tonsillectomy is done by monopolar electrocautery, bipolar scissors or cold instruments. First the mucosa of the anterior palatinal arch is incised and tonsillar capsule identified, then tonsillar tissue is removed along the capsule. Any bleeding is coagulated either with monopolar or bipolar electrocautery.

PROCEDURE

Tonsillotomy

Tonsillotomy is done using monopolar electrosurgery, bipolar scissors or coblator device. Most of the tonsillar tissue is removed, exceeding the removal behind the line between anterior and posterior palatinal arch so that only thin layer of tonsil tissue is left over the tonsillar capsule.

Sponsors & Collaborators

  • Oulu University Hospital

    lead OTHER

Principal Investigators

  • Olli-Pekka Alho, MD, PhD · Oulu University Hospital, University of Oulu

  • Aleksi EJ Laajala, MD · Oulu University Hospital, University of Oulu

  • Paulus Tokola, MD · Oulu University Hospital, University of Oulu

  • Timo J Autio, MD, PhD · Oulu University Hospital

  • Timo J Koskenkorva, MD, PhD · University of Oulu

  • Pasi Ohtonen, M. Sc. · Division of Operative Care, Oulu University Hospital, Finland

  • Esa Läärä, PhD. · Oulu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-08
Primary Completion
2023-06-09
Completion
2023-06-09

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04657549 on ClinicalTrials.gov